Elicit vs Embase AI

Elicit is an AI research assistant for researchers gathering and assessing evidence. Its Research Agent draws on scientific databases, academic journals, public data sources, uploaded documents, a corpus of 138 million academic papers, and the wider web. A session can use up to 20 uploaded resources, including PDF, DOCX, XLSX, PPTX, and JPG files. Elicit offers Research Agent sessions, Research Reports, and Systematic Reviews, and supports AI-generated claims with sentence-level citations to underlying sources. It can find up to 1,000 relevant papers and analyze up to 20,000 data points at once. Research Reports export as PDF or Word, tables as CSV or Excel, and references as RIS or BIB. Elicit runs on the web and provides an API, but API access requires Pro or above. Its MCP server connects to Claude Desktop, Claude Code, and other compatible clients using OAuth 2.0. Basic is free with limited usage for Research Agent and Research Reports; Plus costs $11 a month. Pro is $39 a month and Scale is $89 a month. Elicit states that it has achieved SOC 2 Type II compliance.

Embase AI is Elsevier’s natural-language search tool for biomedical literature. It searches Embase, which the product page says contains 47 million records, and summarizes findings from the 30 most relevant peer-reviewed articles. Users can filter by publication year, publication type and study type, or extend searches to preprints, conference abstracts, ClinicalTrials.gov studies, and articles in press or in process. Summaries link to relevant articles, with references ranked through term-based retrieval and then neural semantic ranking. Users can inspect the AI-generated Embase query, refine it by opening results in Embase, or copy the query text. Follow-up questions and session export support continued searching and record keeping. Elsevier says information is not stored in the LLM or used for training. It presents the product for biomedical research, including users in pharma, medtech, universities and libraries. Embase AI is paid, has a three-day trial, and lists no price; prospective customers can request a demo. It is available on Android, iOS, macOS, web and Windows.